Project Topics Seminar Topics School of Nursing Exam PDF Sign Up
Search Topic
PARKLYN
ERVICES
· RC: 2994849

Topics, Materials & Software

Past Questions & Answers

Business Plan & Partnership

School Information and Courses Offered

Universities Courses Information

Polytechnics Courses Information

Colleges of Education Courses Information


The Enterprise Risk Management in Pharmaceutical Company

The Enterprise Risk Management in Pharmaceutical Company

@SparklynServices
WhatsApp Channel

DEDICATION

This research material, titled “The Enterprise Risk Management in Pharmaceutical Company” is dedicated to God for His boundless grace and guidance. It is also a tribute to all computer enthusiasts whose contributions made my research journey smoother and enriched my documentation process, making the experience truly fulfilling.




ACKNOWLEDGEMENT

I am profoundly grateful to everyone who contributed to the successful completion of this project. I am especially grateful to my Supervisor (Name), the Head of Department (Name), and the Lecturers in the Department of Business Administration and Management (BAM) for their invaluable guidance and support. I also acknowledge the contributions of authors and scholars whose works on The Enterprise Risk Management in Pharmaceutical Company provided essential insights. Special thanks go to my study area (and any funding organizations, if applicable) for their financial assistance. I am equally thankful to stakeholders, including mentors, teachers, and colleagues, for their encouragement and support. Finally, I deeply appreciate my family and friends for their patience and unwavering support throughout this journey. Your contributions have been instrumental in making this research a reality.




PRELIMINARY PAGES


CHAPTER ONE

INTRODUCTION


    CHAPTER TWO

    LITERATURE REVIEW

    • 2.1 Introduction
    • 2.2 Conceptual Review
    • 2.3 Theoretical Framework
    • 2.4 Empirical Studies
    • 2.5 Research Gaps
    • 2.6 Summary of Literature Review

    CHAPTER THREE

    RESEARCH METHODOLOGY

    • 3.1 Introduction
    • 3.2 Research Design
    • 3.3 Population of Study
    • 3.4 Sampling and Sampling Technique
    • 3.5 Validation of Research Instrument
    • 3.6 Method of Data Collection
    • 3.7 Method of Data Analysis
    • 3.8 Questionnaire Administration
    • 3.9 Ethical Consideration
    • 3.10 Statistical Analysis

    CHAPTER FOUR

    DATA ANALYSIS, RESULT AND DISCUSSION

    • 4.1 Introduction
    • 4.2 Presentation and Analysis of Data
    • 4.3 Re-statement of Research Questions
    • 4.4 Test of Hypotheses
    • 4.5 Discussion of Findings

    CHAPTER FIVE

    SUMMARY, CONCLUSION AND RECOMMENDATION

    • 5.1 Introduction
    • 5.2 Summary of Findings
    • 5.3 Conclusion
    • 5.4 Recommendation
    • 5.5 Suggestion for Further Study

    REFERENCES

    APPENDIX A - “QUESTIONNAIRE”



    ABSTRACT

    How pharmaceutical companies successfully implements an Enterprise Risk Management (ERM) programme, to identify and manage potential risks, can mean the difference between financial freedom and financial despair. The Committee of Sponsoring Organization (COSO) guidelines, a voluntary private sector organization in the United State, has developed internal control guidelines to provide guidance to executive management and governance entities on critical aspects of organizational governance, business ethnic, internal control, fraud and financial reporting. This chapter will discuss an approach to build an ERM implementation plan within Fidson Healthcare Limited, by outlining the responsibilities and influence of industry participants, sales forces, middle- management and senior leadership and the ways in which they focus on monitoring and developing the risk mitigation process. The influences of technologies are integrated and new directions, such as e-mails and e-detailing. Thus, in order to mitigate business risk, some companies use Enterprise Risk Management concept (ERM, developed by COSO) to establish an effective corporate management system. The researcher is thus, quickening to use this piece of study to evaluate the need of ERM in Fidson Healthcare Limited. Data were sourced from the primary and secondary sources of data, using words by other authors and information gathered from the oral interview carried out on the respondent. Hypothesis was formulated and tested using Chi- square method. Finally, it was discovered that there is need for Enterprise Risk Management tools Pharmaceutical Companies (Fidson Healthcare Limited), for them to achieve their business objectives and for effectiveness in running of their businesses.



    The Enterprise Risk Management in Pharmaceutical Company



    Introduction

    1.1 Background Of The Study

    In the business world, every individual and businesses are exposed to risk. For any business to exist and survive, the business has to go through some challenges of risk. Risks are in existence simply because entities, companies and organizations have ‘assets’ of a material or immaterial nature that could be subject to physical harm that has consequences on the known entity (Andy Osborne 2012- Risk Management made easy).

    In Risk management, there is no formal definition of. Risk has been defined by different scholars based on their level of understanding. One of such definition of risk is “Risk implies exposure to uncertainty or threat (Kannan and Thangavard, 2008) and “a decision to do nothing to explicitly avoid the opportunities that exists and leaving threats unmanaged.”(Webster, 2007). Also, Risk can be defined as the combination of the probability of an event and its consequences (ISO/IEC Guide 73).

    Risk management therefore, is a proactive approach to reduce threats, increase opportunities, and optimize achievements of objectives (Pearce and Robinson, 2000, Webster, 2004,’ Gray and Larson, 2006.’Rejda, 2001). Also, Andy Osborne 2012 says risk management is a structured and coherent approach to identify, analyze and manage risks that affects the strategy, process, people and technologies.

    “Prior the emergence of ERM, organizations used to handle their risk individually and independently, using the traditional ways of risk managements of”:

    • Identification
    • Evaluation
    • Control

    As time goes on, companies now realized that it would favour them more to treat their risks as a whole (portfolio), as would surely reduce its costs and expenditure incurred in managing risk. And that was how ERM came into existence in 2004 Olaf Passenheim, 2011).

    ERM is a holistic way of treating risk in an organization, Olaf Passenheim-2011). ERM is a risk cover that takes into considerations, all types of risks faced by an organization, such as – Strategic, Financial, Operation and Hazard risks. These frameworks are the ways ERM can be effected by an organization (Olaf Passenheim- 2011).

    ERM is usually decided and effected by senior managers of an organization, and after the decision is taken, it passes on to other personnel of the organization, until it gets to the lowest rank of the organization. This is because; everyone has to have knowledge of the way risk is being managed in their organization.

    In the corporate environment, COSO (2004) also says Enterprise risk management is the best tool to be used in combating all risk available and causing damages to the industry; using its frameworks guide of:

    • Strategic Risk
    • Operational Risk
    • Financial/Reporting Risk
    • Hazard/Compliance Risk
    • Enterprise risk management is a procedure to minimize the adverse effects of a possible financial loss by:
    • Identifying potential sources of loss
    • Measuring the financial consequences of a loss occurring.
    • Using controls to minimize actual losses or their financial consequences (Olaf Passenheim-2011).

    A closer look on Enterprise risk management in pharmaceutical company reveals that in Fidson Healthcare limited, that there are lots of risks that need proper management. Some of the risks are IT risk, financial reporting risks, environmental or legal risks, production risk and administrative risk. With the situation of all risk exposures in the industry, the industry needs to set goals of risk management which are to protect the industry against downside risks, to manage volatility around business and financial results of the industry and to optimize risk and returns of Fidson Healthcare Limited.


    1.2 Statement Of The Problems

    § It’s been discovered that some pharmaceutical companies, considers and handles their risk individually and independently( Traditional ways of risk management); like fire risk, theft risk and so on, thereby neglecting some main risk they encounter during operations.

    1. Also pharmaceutical companies spend much time and resources in handling those risk traditionally, and when not properly handled, lead to huge losses on their part.
    2. It has also been discovered that most pharmaceutical companies, have not been introduced to or have knowledge of a more advanced and effective way of managing risk (ERM) in their organization.
    3. Also, some of the pharmaceutical companies who have adopted ERM as a practical way of handling corporate risk find it difficult to cover the whole ERM frameworks; rather, they concentrate on a section of the frameworks and pay little or no attention to the others.

    These have been giving the industry a reputation of low profitability and returns on investments.


    1.3 Objectives Of The Study

    The aim and objectives of this research study are:

    1. To know and examine previous risk management strategy used by Fidson Healthcare Limited.
    2. To know if ERM is being used to manage risk in Fidson Healthcare Limited.
    3. To find out the mostly used ERM frameworks in Fidson Healthcare Limited.
    4. To know and examine the challenges faced by Fidson Healthcare Limited, in the chosen ERM framework in managing their risk.

    1.4 Relevant Research Questions

    The following research questions were raised from this study:

    1. What previous risk management strategy was used by Fidson Healthcare Limited in managing their risk?
    2. Is ERM a practical option for managing risk in Fidson Healthcare Limited?
    3. Which of the ERM frameworks is mostly used by Fidson Healthcare Limited?
    4. What challenges does Fidson Healthcare Limited encounter in the course of using the ERM frameworks?

    1.5 Relevant Research Hypothesis

    The hypothesis was extracted from the research questions, to guide the researcher in the course of this study.

    H0: There would be no significant influence of the adopted ERM framework on Fidson Healthcare Limited.

    H1: There will be positive significant influence of the adopted ERM framework on Fidson Healthcare Limited’s risk managements.


    1.6 Scope And Limitations Of The Study

    The study focuses on pharmaceutical industries; their employees, management and their products, while gathered information will be within this industry. Specifically, Fidson Healthcare limited will be focused on, among the fast rising pharmaceutical companies based in Lagos, using COSO ERM Frameworks in managing their organizational risks.

    However, the limited time scarce and financial resources at the researcher’s disposal, calls for this limited scope.


    1.7 Significance Of The Study

    This study will be beneficial in the following ways:

    1. It will be of immense benefits to body of knowledge in the area of investigation.
    2. It will serve as an instrument of enlightenment to industries, especially pharmaceutical companies on the need for an effective management of risk using Enterprise risk management tools/frameworks.
    3. The finding of this study will also provide a basis where Fidson Healthcare limited will use Enterprise risk management to safe and secure the business risk of the industry.
    4. Similarly, it will help academia and scholars to expand their frontiers of knowledge and provide s basis from which future researchers may benefit.

    1.8 Definition Of Terms

    Risk:
    • It is the possibility of an unfortunate occurrence (Aneke J.I (1998).
    • It is the uncertainty of a loss (Dickson (1981:11).
    • It is the chance of loss (Dickson (1981:11).
    Harzard:

    They are events or conditions that creates or increases the chance of loss arising from a given peril (Irukwu(1990:67).

    Peril:

    It is the cause of a loss or a loss producing agent, without which there can be no loss, even though the uncertainty of event may exist (Aneke(1998).

    Risk Management:

    Is a proactive approach to reduce threats and adverse effects of risk increasing opportunities and optimize achievements of objectives (Pearce and Robinson(2000; Webster(2004; Gray and Larson(2006; Rejda(2011).

    Entreprise Risk Management:

    Is a procedure to minimize the adverse effects of a possible financial loss in an organization (Olaf Passenheim(2011).

    Hazard Risk:

    It refers to any source that may cause harm or adverse effects, such as equipment lost due to natural disaster (Skipper and Kwon, 2007)

    Financial Risk:

    It refers to any loss due to economic conditions such as foreign exchange rates, derivatives, liquidity risk and credit risk (Jones, 2006; Benston et al.,2003) .

    Strategic Risks:

    Is the uncertainty of loss of a whole organization and the loss may be profit or non-profit (Li and Liu (2002).

    Operational Risk:

    It refers to risk of direct or indirect loss resulting from inadequate or failed internal processes, people and systems or from external events (Basel Committee (2001).


    CHAPTER TWO

    2.0 Literature Review

    2.1 Introduction

    This chapter focuses on the review of related literature. A literature review includes the current knowledge as well as theoretical and methodological contributions to a particular topic. It documents the state of the art with respect to the topic you are writing. It surveys the literature in the topic selected. In this research work the literature review includes the conceputal review, theoretical framework, the review of related literature …


    How to Download the Complete PDF Material (Table of Contents, Abstract, Chapter 1-5, and References)


    Above is a preview excerpt of the full study on “The Enterprise Risk Management in Pharmaceutical Company”. The complete material, including all five chapters, is available for download upon request.

    Defense Procedure for Business Administration and Management (BAM) Researchers


    In preparation for defending a project or seminar on The Enterprise Risk Management in Pharmaceutical Company, it is imperative that as a nursing student, you demonstrate comprehensive knowledge of your research. The defense process is structured to include presenting your work, answering questions, and illustrating its pertinence. Initially, provide a succinct yet thorough introduction to your research topic, emphasizing its importance and the objectives, ensuring that both the audience and the External Examiner can understand the scope of your study.


    Prior to your defense, be thoroughly acquainted with your research abstract and the critical elements of Chapter One, including motivation for embarking on this research, problem statement, objectives, and significance. In Chapter Two, be ready to cite at least two references from the literature review. For Chapter Three, you should be equipped to discuss the methodologies, tools, and techniques utilized. In Chapter Four, defend your research by justifying the findings and linking them to your research objectives.


    Conclude your defense by succinctly summarizing the study and offering insightful, evidence-based recommendations. A professional dress code, such as wearing a suit and tie, is vital to create a favorable impression and elevate your presentation.


    During the question and answer segment, the External Examiner may pose questions pertaining to your research. If confronted with a challenging or irrelevant question, respond diplomatically with, “Sorry, Sir/Madam, the question asked is beyond the scope of my study.” Whenever possible, direct your answers back to your research findings to reinforce your expertise.


    Page Content Headings - The Enterprise Risk Management in Pharmaceutical Company


      See also - The Impact of Business Failure in Nigeria
      Download Material (Docx)